Destructive Thyroiditis Induced by Lenvatinib in Three Patients with Hepatocellular Carcinoma (Q58544320)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

case report

0 references

title

Destructive Thyroiditis Induced by Lenvatinib in Three Patients with Hepatocellular Carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

main subject

hepatocellular carcinoma

1 reference

Masashi Hirooka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Hironori Ochi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Atsushi Hiraoka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Yohei Koizumi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Bunzo Matsuura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Kouji Joko

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Kojiro Michitaka

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Masanori Abe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Yoichi Hiasa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

language of work or name

English

0 references

publication date

17 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

page(s)

791-795

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.

29 April 2020

cites work

1 reference

12 December 2020

Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase

1 reference

12 December 2020

Shrinkage of thyroid volume in sunitinib-treated patients with renal-cell carcinoma: a potential marker of irreversible thyroid dysfunction?

1 reference

12 December 2020

Clinical characteristics of thyroid abnormalities induced by sunitinib treatment in Japanese patients with renal cell carcinoma

1 reference

12 December 2020

Sunitinib-Induced Thyrotoxicosis Followed by Persistent Hypothyroidism with Shrinkage of Thyroid Volume

1 reference

12 December 2020

Sorafenib induced thyroiditis in two patients with hepatocellular carcinoma

1 reference

12 December 2020

Inappropriate elevation of serum thyrotropin levels in patients treated with axitinib.

1 reference

12 December 2020

Pazopanib versus sunitinib in metastatic renal-cell carcinoma

1 reference

12 December 2020

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage

1 reference

12 December 2020

Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models

1 reference

12 December 2020

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

1 reference

12 December 2020

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial

1 reference

12 December 2020

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.

1 reference

12 December 2020

Risk Factors for New Hypothyroidism During Tyrosine Kinase Inhibitor Therapy in Advanced Nonthyroidal Cancer Patients.

1 reference

12 December 2020

10.2169/INTERNALMEDICINE.1874-18

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30333428%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

PubMed publication ID

30333428

1 reference